Michelle Tran - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Michelle Tran ... By: California Institute for Regenerative Medicine … Continue reading →

Steven Wang - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Steven Wang is... By: California Institute for Regenerative Medicine … Continue reading →

Ted Zhu - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Ted Zhu is a W... By: California Institute for Regenerative Medicine … Continue reading →

Vanessa Yu - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Vanessa Yu is ... By: California Institute for Regenerative Medicine … Continue reading →

Cambridge entrepreneur Jonathan Milner has launched a new, ethical stem cell business in the UKs technology capital and Axol Bioscience has shipped its maiden product just four months after startup. The company, which is tilting at a multibillion dollar global market, has a real ace to play as its product requires no testing on animals. Its first customer is the University of Cambridge. Neurobiology is one of the major sectors of biomedical research with an annual total public and private funding over $15 billion worldwide. Dr Shi said the current method of studying diseases of the nervous system involved the generation of animal models. However, genetically modifying animals to mimic human disease was extremely time consuming, expensive and ethically unsound, he said. Additionally, the models often failed to recapitulate the relevant human neuropathologies. A burning desire of many researchers is to study genuine human tissue samples however there are only very limited amounts of frozen postmortem brain tissue samples available for research, and using aborted foetal tissues for research is also ethically controversial. The Nobel Prize-winning cell reprogramming technology and proprietary neural tissue generation technology together provide an opportunity to derive an unlimited amount of patient-specific brain stem cells, which … Continue reading →

ANN ARBOR A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders. The findings, reported by a team of scientists from the University of Michigan Medical School and colleagues, use a technique that could be called epilepsy in a dish. By turning skin cells of epilepsy patients into stem cells, and then turning those stem cells into neurons, or brain nerve cells, the team created a miniature testing ground for epilepsy. They could even measure the signals that the cells were sending to one another, through tiny portals called sodium channels. In neurons derived from the cells of children who have a severe, rare genetic form of epilepsy called Dravet syndrome, the researchers report abnormally high levels of sodium current activity. They saw spontaneous bursts of communication and hyperexcitability that could potentially set off seizures. Neurons made from the skin cells of people without epilepsy showed none of this abnormal activity. They report their results online in the Annals of Neurology, and have further work in progress to create induced pluripotent stem cell … Continue reading →